498PPhase I/II study of valproic acid (VPA) and short-course radiotherapy (SCRT) plus capecitabine (CAP) as preoperative treatment in low-moderate risk rectal cancer (V-shoRT-R3). (23rd October 2018) - Budillon, A; Delrio, P; Pecori, B; Tatangelo, F; Di Gennaro, E; Romano, C; D'Angelo, V; Marone, P; Granata, C; Cavalacanti, E; De Stefano, A; Pace, U; et al.